advanced purification methods

Emervax is a vaccine company founded by leaders in RNA biochemistry and infectious diseases to chart a new course in vaccination. Leveraging circRNA technology, advanced purification methods and innovative delivery strategies, it focuses on creating groundbreaking vaccines against viruses and difficult-to-treat cancers. Its modular multipurpose vaccine platform addresses global health challenges with next-generation vaccines for emerging viruses and chronic diseases.

Read more

circRNA technologyinnovative delivery strategiesvaccine development